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Abstract 
The brain’s neocortex is anatomically organized into grey and white matter, which are mainly 
composed by neuronal and glial cells, respectively.  The neocortex can be further divided in 
different Brodmann areas according to their cytoarchitectural organization, which are associated 
with distinct cortical functions. There is increasing evidence that brain development and function 
are governed by epigenetic processes, yet their contribution to the functional organization of the 
neocortex remains incompletely understood. Herein, we determined the DNA methylation 
patterns of grey and white matter of dorsolateral prefrontal cortex (Brodmann area 9), an 
important region for higher cognitive skills that is particularly affected in various neurological 
diseases. For avoiding inter-individual differences, we analyzed white and grey matter from the 
same donor using whole genome bisulfite sequencing, and for validating their biological 
significance, we used Infinium HumanMethylation450 BeadChip and pyrosequencing in ten and 
twenty independent samples respectively. The combination of these analysis indicated robust 
grey-white matter differences in DNA methylation. What is more, cell type-specific markers were 
enriched among the most differentially methylated genes. Interestingly, we also found an 
outstanding number of grey-white matter differentially methylated genes that have previously 
been associated with Alzheimer’s, Parkinson’s, and Huntington’s disease, as well as Multiple 
and Amyotrophic lateral sclerosis. The data presented here thus constitute an important 
resource for future studies not only to gain insight into brain regional as well as grey and white 
matter differences, but also to unmask epigenetic alterations that might underlie neurological 
and neurodegenerative diseases.  
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Introduction  
The neocortex is the largest structure in the human brain representing 82% of total brain mass  
and containing more than 80 billion cells. It is the brain region where cognition, language and  
complex behaviors take place and are being planned, and where neurons and glial cells form a  
patterned structure that defines the two main divisions of the brain: the grey and the white  
matter. The grey matter, the greyish appearance of which is the consequence of the presence  
of cell bodies, is mainly composed by neurons and glial cells (glia/neuron ratio ~ 1.5) whereas  
the white matter, the whiteness of which is due to the myelin that covers axons, is mostly  
composed by glial cells (glia/neuron ratio ~ 15.5) (Azevedo et al., 2009). Therefore, unraveling  
the epigenetic profiles governing grey and white matter will provide information about the  
epigenetic landscapes of neurons and glial cells. This quest has recently started to be  
addressed using genome-wide (Guintivano et al., 2013; Iwamoto et al., 2011; Kessler et al.,  
2016; Kozlenkov et al., 2014; Labonte et al., 2013) and whole-genome approaches (Lister et al.,  
2013). In these studies, immunolabeled neuron and glial cells were isolated and their DNA  
methylation patterns examined allowing for the comparison of pure populations of cellular types,  
yet without considering their spatial organization. This is an important handicap because several  
studies have highlighted the importance of considering anatomical compartments. Indeed,  
neuron and glial cells show specific spatial profiles of gene expression according to their  
emplacement within anatomical structures (Bohland et al., 2010; Ko et al., 2013), which is also  
evident by characteristic DNA methylation profiles indicating an important spatial regulation as  
shown in other brain areas (Davies et al., 2012; Hernandez et al., 2011; Kozlenkov et al., 2016;  
Ladd-Acosta et al., 2007; Lee et al., 2011; Sanchez-Mut et al., 2013; Xin et al., 2010).  
In order to consider the spatial regulation of cerebral cortex and to discern the DNA methylation  
profiles of grey and white matter, we focused on dorsolateral prefrontal cortex Brodmann area 9  
(BA9) because it is involved in higher cognitive skills such as memory and cognition (Wood and  
Grafman, 2003), and because it is also frequently altered in neurological diseases, including  
Alzheimer’s disease (AD) (Dournaud et al., 1995; Grouselle et al., 1998; Igarashi et al., 2011),  
Parkinson’s disease (PD) (Dumitriu et al., 2012; Lanoue et al., 2013; Lanoue et al., 2010),  
Huntington’s disease (HD) (Hoss et al., 2015; Labadorf et al., 2015; Mina et al., 2016), as well  
as mood and bipolar disorders (Brooks et al., 2010; Fitzgerald et al., 2006; Whitfield et al.,  
2015). We performed a whole genome bisulfite sequencing analysis (WGBS) of grey and white  
matter providing a comprehensive catalogue of DNA methylation profiles at base-pair  
resolution. In order to avoid inter-individual variability, we acutely dissected donor-matched grey  
and white matter from postmortem samples. Importantly, we validated the biological significance  
of these findings using an independent cohort of prefrontal cortex samples by Infinium 450K  
array and pyrosequencing.  
Methods  
Page 4 of 32Synapse
This article is protected by copyright. All rights reserved.
Human samples – Post-mortem tissues were obtained from the Institute of Neuropathology 
Brain Bank (HUB-ICO-IDIBELL Biobank) following the practices and expertise of BrainNet 
Europe Bank (http://www.brainnet-europe.org/) "Network of Excellence" funded by the 
European Commission in the 6th Framework Program "Life Science" (LSHM-CT-2004-503039). 
All samples were obtained in agreement with ethical issues and legislations defined by the 
European Union and after the approval of the local Ethic Committee. DNA was extracted from 
grey and white matter of dorsolateral prefrontal cortex (Brodmann area 9). The EZ DNA 
methylation kit (Zymo Research) was used for bisulphite concersion of all DNA samples used as 
previously described (Bibikova et al., 2011). 
Previously reported WGBS gray and white matter data from the same control donor were used 
(GSE47966 GSM1173772 – Grey matter – (Lister et al., 2013); GSM1279516 GSE52271– 
white matter – (Sanchez-Mut et al., 2016); female 64 years old). Five additional control grey and 
white matter were hybridized on 450K arrays (three females and two male aged 69.4 ±4.3 and 
four females and one male aged 64.4±9.7 respectively). A third set of ten control grey and ten 
white matter samples was used for pyrosequencing validation (seven females and three male 
aged 70.3 ±3.8 and eight females and two male aged 69.1±5.1 respectively).   
Pyrosequencing – The set of primers for PCR amplification and sequencing (Supplementary 
table 1) were designed using the software PyroMark assay design version 2.0.01.15 (Qiagen); 
amplification primers hybridize with CpG-free sites to ensure methylation-independent reaction 
and one primer (opposite to the sequencing primer) is biotinylated to convert the PCR product 
to single-stranded DNA templates.  We used 1ul of bisulphite-treated DNA for each PCR. We 
used (Bibikova et al., 2011)the Vacuum Prep Tool (Quiagen) to prepare single-stranded PCR 
products according to manufacturer’s instructions.  Pyrosequencing reactions and methylation 
quantification were performed in a PyroMark Q24 System version 2.0.6 (Qiagen). 
Whole-genome bisulfite sequencing data processing – Sequence alignment and methylation 
calling were performed with version 0.7.4 of Bismark software (Krueger and Andrews, 2011). 
We used hg19 as reference genome and retrieved genomic information from Biomart (Haider et 
al., 2009). SAM/BAM and BED files handling was done using SAMtools (Li et al., 2009), 
bedtools (Quinlan and Hall, 2010) and Tabix (Li, 2010). Statistical analysis and graphic 
representation was performed with R (http://www.R-project.org) and libraries multicore and 
ggplot2. We defined the promoter region as 2 kb flanking the transcription start site (TSS). TSS 
was considered to be the upstream-most base of all the transcripts of the gene. Smoothed 
methylation profiles were generated following the BSmooth pipeline (Hansen et al., 2012). 
CpG distance correlation – We assessed distance correlation of CpG in close proximity 
gathering information about methylation and relative distance up to 2000 bases away from all 
CpG sites and correlating pair-wise methylation at single CpG sites for each relative distance. 
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Detection of differentially methylated regions – Differentially methylated regions (DMR) were  
identified as regions with more than 5 consecutive CpG sites that showed a consistent  
difference between the 95% CI of the smoothed methylation profile (Hansen et al., 2012).  
Detection of histone marks – We obtained human histone marks for human adult brain inferior  
temporal lobe available at the ENCODE project (GSE17312) and CCAT peak caller(Xu et al.,  
2010) with the standard parameter for histone marks.    
Microarray-based DNA methylation analysis with Infinium 450k array – The Infinium methylation  
assay was carried out as described previously (Bibikova et al., 2011). P-values for probes  
covering and following consistent tendencies with the identified DMRs were obtained using  
Kruskal–Wallis test and false discovery rate (FDR<0.05) adjustment for multiple comparisons.  
RNA expression profiling – RNA expression profiling was performed following the Pico Profiling  
method(Gonzalez-Roca et al., 2010). Each sample analyzed by WGBS was also hybridized to a  
Human Gene ST 1.0 Arrays (Affymetrix). The arrays were scanned in a GeneChip Scanner  
3000 (Affymetrix). CEL files were generated from DAT files using GCOS software (Affymetrix).  
To generate the log2 expression estimates, overall array intensity was  normalized between  
arrays and the probe intensity of all probes in a probeset summarized to a single value using  
RMA (Robust Multichip Average) algorithm(Irizarry et al., 2003).  
Disease-associated genes – AD-associated genes were obtained from AlzGene database  
(Bertram et al., 2007), PD-associated genes from PDGene (Lill et al., 2012), Amyotrophic lateral  
sclerosis-associated genes from ALSGene (Lill et al., 2011), and Multiple Sclerosis- associated  
genes from MSGene (Lill CM, 2012). Relative gene amounts was assayed using two-tailed  
Fisher’s exact test and the level of significance (alpha) set at p<0.05.  
Results  
WGBS patterns  
We performed WGBS of grey and white matter from BA9 obtained from the same patient in  
order to avoid inter-individual variability. 19x107 paired-end reads corresponding to a global  
coverage of ~10x sequencing depth and interrogating ~94% of genome were successfully  
mapped and obtained for both samples. Closer inspection indicated that more than 109 single  
Cs (98%) were covered in both samples with 3.8x108 (6,2%) and 3.2x108 (5,2%) of reads  
methylated in grey and white matter respectively. In detail, 27.4x107 (79,3%) of CGs,  8.6x107  
(3,8%) of CAs, 2.8x107 (1,3%) of CTs and 0.7x107 (0,5%) of CCs reads were methylated in grey  
matter whereas 28.5x107 of CGs (78,9%), 3.5x107 (1,5%) of CAs, 1.1x107 (0,5%) of CTs and  
0.6x107 (0,3%) of CCs were methylated in white matter. Thus, we observed higher levels of non- 
CG methylation in grey matter (30,8% vs. 15,3% of total C methylated reads were in non-CG  
context) while CG methylation was similar in both samples (79,3% vs. 78,9%). Noticeably,  
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similar results were obtained in immunolabeled neuronal and gial cells suggesting that this 
pattern represents a general tendency in the brain (Lister et al., 2013).  
Next, we asked how methylation values were distributed. As expected, we observed a similar 
bimodal distribution of CG methylation in both samples with ~88% of Cs methylated (>66% 
average methylation value) and ~5% of Cs unmethylated (<33% average methylation value). 
On the contrary, non-CG methylation showed a single distribution with most of Cs being 
unmethylated (~90% of total Cs with average methylation value lower than 33%) even in grey 
matter where overall methylation levels were higher (Supplementary figure 1).  
In keeping with previous results (Heyn et al., 2012), we observed a significant correlation 
between neighboring CG methylation site levels (Supplementary figure 2). On the contrary, no 
correlation was observed for non-CG methylation. This might be explained by the fact that CG 
methylation shows a bimodal distribution and tends to form clusters whereas non-CG 
methylation tends to be more scattered (Hebestreit et al., 2013; Lister et al., 2013).  
Next, we assessed the relation between CG and non-CG methylation. To solve the problem of 
the scattered pattern of non-CG methylation, we defined flanking windows of 500bp and 2kb 
around the CpG islands and interrogated the non-CG methylation in the neighborhoods of CG 
methylated and unmethylated islands. Interestingly, CG and non-CG methylation were 
correlated in grey and white matter samples with the former showing higher correlation values 
(Supplementary Figure 3; R= 0.51 p-val<0.001 and R = 0.21 p-val<0.001; Pearson correlation 
values for 500bp and 2kb windows respectively). In keeping with previous results(Guo et al., 
2014; Kulis et al., 2015; Sun et al., 2016; Ziller et al., 2011), we observed a correlation between 
CG and non-CG methylation which was stronger in grey matter where neurons, with higher 
levels of non-CG methylation, are more abundant (Guo et al., 2014; Lister et al., 2013; Sun et 
al., 2016). 
Considering all of the aforementioned, we then decided to focus all subsequent analyses on CG 
methylation for the following reasons: 1) The functional relevance of CG methylation in gene 
regulation has been unequivocally demonstrated (Vinson and Chatterjee, 2012); 2) the 
correlation between neighboring CG methylation site levels allows the use of smoothing 
algorithms increasing the power, accuracy and sensitivity to detect differentially methylated 
regions (DMRs) (Hansen et al., 2012); 3) high-density array platforms are designed 
preferentially for interrogating CG methylation sites with the non-CG methylation probes being 
almost negligible; and 4) in contrast to the scattered pattern of non-CG methylation, differentially 
methylated CG loci can be precisely determined facilitating their validation using locus-specific 
techniques such as pyrosequencing. 
Differentially methylated regions 
To assess CG methylation in more detail, we used previously published smoothing methods 
(Hansen et al., 2012) and found 26914 DMRs between grey and white matter of BA9 (mean 
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size ~ 102-103 bp; Figure 1A). These DMRs tend to lie on functional relevant regions as 
expected by the regulatory role of CG methylation (3,4 OR; Bootstrap pval<0.001). 6447 DMRs 
were located on promoters (4,1 OR; Bootstrap pval<0.001), 18900 on gene bodies (1,6 OR; 
Bootstrap pval<0.001), 6292 on enhancers (7,4 OR; Bootstrap pval<0.001), 1046 on TFBS (7,1 
OR; Bootstrap pval<0.001) and 4689 on regions without regulatory function (0,2 OR; Bootstrap 
pval<0.001) (Figure 1B). Similar enrichment of differentially methylation regions in enhancer 
regions have been previously observed (Kozlenkov et al., 2014; Sun et al., 2016), supporting 
the accuracy of our results.  
Epigenetic crosstalk between DNA methylation and histone marks 
After that, we interrogated the relation between DNA methylation and histone marks using the 
comprehensive epigenetic profiling of human brain samples within the Roadmap project 
(Bernstein et al., 2010) because there is an important crosstalk between both epigenetic 
marks(Cedar and Bergman, 2009), in particular also for higher cognitive functions(Miller and 
Sweatt, 2006). As expected, H3K4me3 and H3K9ac, which are enriched on active promoters, 
tend to be non-methylated (Supplementary figure 4). In contrast, H3K9me3, a marker of 
heterochromatin, shows higher levels of DNA methylation. Furthermore, H3K36me3, which 
marks gene bodies of active genes, shows high levels of DNA methylation and H3K27ac, 
H3K4me1 and H3K27me3, which mark enhancers and polycomb genes, respectively, show 
intermediate DNA methylation levels. Noticeably, most of the DMR co-localized with 
euchromatin marks (H3K4me1, H3K4me3, H3K36me3, H3K27ac; 8,3 OR; Bootstrap 
pval<0.001) suggesting that the majority of DNA methylation differences between grey and 
white matter affect regulatory active regions whereas heterochromatin regions remain largely 
unaltered (H3K9me3; 0,3 OR.; Bootstrap pval<0.001): DMRs tend to lie on euchromatin regions 
27,6 times more than on heterochromatin regions (Bootstrap pval<0.001). In detail, 8307 DMRs 
were located on H3K4me3 (12,7 OR; Bootstrap pval<0.001), 11959 on H3K27ac (7,9 OR; 
Bootstrap pval<0.001), 1739 on H3K27me3 (7,1 OR; Bootstrap pval<0.001), 7836 on H3K4me1 
(5,8 OR; Bootstrap pval<0.001) and 2185 on H3K36me3 (2,6 OR; Bootstrap pval<0.001; Figure 
1B). Supporting these results, we observed an important overlap between DNA sensitive sites 
in human brain samples (ENCODE/Duke University; Frontal cerebrum) and DMRs (23,1 OR; 
Bootstrap pval<0.001), which suggests that DMR tend to be located on open chromatin regions. 
Closer inspection revealed that 1045 DMRs were located on bivalent domains 
(H3K4me3+H3K27me3) (17,6 OR; Bootstrap pval<0.001) indicating that bivalent domains were 
the most overrepresented histone mark category of the genome.  
Correlation between DNA methylation and RNA expression 
In addition, we examined the correlation between DNA methylation and RNA values using 
GeneChip human gene 1.0ST array data (Supplementary table 2). In keeping with the idea that 
promoter DNA methylation represses RNA expression (Kelly et al., 2012), promoter DNA 
methylation was negatively correlated with gene expression (Figure 1C; Grey matter R =  -0.49; 
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White matter R = -0.47; Pearson correlations, p-val <0.001), supporting the biological 
significance of the observed DMRs. However, in contrast with previous observations (Zemach et 
al., 2010), no significant differences in RNA expression were observed in relation to gene body 
DNA methylation (data not shown). 
Validation of WGBS using 450K Illumina Platform and pyrosequencing 
In order to validate WGBS results, we took advantage of the Infinium Human Methylation 450 
BeadChip Kit which interrogates more than 485,000 methylation sites per sample at single-
nucleotide resolution. DNA methylation profiles obtained from both platforms were highly 
correlated (R2= 0.957 and R2= 0.962 for grey and white matter respectively). In detail, from 
11860 DMRs identified by WGBS (Supplementary table 3), 4496 (38%) were also covered by 
450K arrays and 3820 (85%) of those were technically validated between both technologies 
(Supplementary figure 5). For further biological validation and for avoiding subject-specific 
differences, we used an additional five grey and five white matter samples. Importantly, 4010 of 
covered DMRs (89,2%) showed consistent tendencies between independent samples 
(Supplementary figure 5) and 2806  (70 %) significant differences (Supplementary table ; 
FDR<0.05)  reinforcing the biological importance of these findings. As expected, a clustering 
analysis of 450K CpGs covering DMRs showed a clear difference of DNA methylation between 
grey and white matter profiles in BA9 (Figure 2). Lastly, these data were also technically and 
biologically validated by pyrosequencing using a third set of ten grey and ten white matter 
samples. WGBS DMRs showing significant differences in the 450K arrays were sorted 
according to their CpG mean differences and the top ranked genes were interrogated by 
pyrosequencing. These results revealed similar DNA methylation differences between grey and 
white matter in WGBS, 450K data, pyrosequencing and RNA expression (Table 1, 
supplementary table 4, and supplementary figure 6). 
Enrichment of DMR on glial and neuronal genes  
Noticeably, we observed an important overlap of DMRs with promoters of neuronal (e.g., ENO2, 
TUBB3, MAP2 and MAPT) and glial genes (e.g., GFAP, GLUL, S100B and NOTCH1 for 
astrocytes and MBP, SOX10, MAG and MOG for oligodendrocytes:  As expected, and in line 
with the negative correlation between promoter DNA methylation and gene expression, genes 
preferentially expressed in neurons were hypomethylated in grey matter whereas genes 
preferentially expressed in glial cells markers were hypomethylated in white matter (Figure 3A). 
Consistently, an outstanding number of genes differentially expressed genes between neurons, 
astrocytes, and oligodendrocytes (Cahoy et al., 2008) also shows differences in DNA 
methylation (Supplementary table 5). 
Next, we compared our data with previously published and NCBI GEO accessible datasets 
investigating DNA methylation differences between neuron and glial cells. Our DMR list 
comprises more than 90% of genes covered by both platforms and differentially methylated in 
the 450K dataset GSE41826 consisting of 29 neuron and glia paired prefrontal cortex samples 
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(average DNA methylation between NeuN+ and NeuN- >5%; FDR<0.05) (Guintivano et al., 
2013). Besides, since human and mouse DNA methylation differences between neurons and 
glial cells are highly conserved(Kessler et al., 2016), we compared our DMR list with the WGBS 
dataset GSM11737786-91 consisting of three paired cortex murine samples (Lister et al., 2013) 
reanalyzed by Kessler et al(Kessler et al., 2016). Our DMR list includes more than 70% of 
genes differentially methylated in Kessler et al. data (Supplementary table 1 Kessler et al., 
2016), supporting the reliability and functional relevance of our observations. 
In addition, we explored the functional particularities of grey and white matter genes with DMRs 
in promoters using GeneCodis tool (Carmona-Saez et al., 2007; Nogales-Cadenas et al., 2009; 
Tabas-Madrid et al., 2012). Differentially methylated genes were enriched in Kyoto 
Encyclopedia of Genes and Genomes (KEGG) (Kanehisa and Goto, 2000) terms associated 
with neuron- and glia-specific processes such as regulation of actin cytoskeleton and axon 
guidance, Gap junctions, and Wnt signaling (Supplementary table 6). Similarly, Protein ANalysis 
THrough Evolutionary Relationships (PANTHER)(Thomas et al., 2003) terms such as synaptic 
vesicle trafficking, acetylcholine, oxytocine, GABA, and glutamate signaling genes were also 
enriched in DMRs between grey and white matter (Supplementary table 7). In this regard, these 
data are in line with the expected gene enrichments, presumably a direct consequence of the 
different composition of cells between grey (neuron-like) and white matter (glial-like). 
Interestingly, KEGG and PANTHER analysis also identified a significant enrichment of DMR in 
genes associated with AD, PD, and HD as well as Amyotrophic lateral sclerosis (ALS) 
(Supplementary tables 6 and 7) indicating that an important fraction of differentially methylated 
genes between grey and white matter are associated with neurodegenerative diseases. 
Disease-associated genes differentially DNA methylated between grey and white matter  
To corroborate these observations, we next took advantage of the AlzGene (Bertram et al., 
2007), PDGene(Lill et al., 2012), ALSGene(Lill et al., 2011), and MSGene(Lill CM, 2012) 
datasets, which constitute independent repositories of genes associated with AD, PD, ALS, and 
Multiple Sclerosis (MS), respectively. From the identified 6447 DMRs on promoters, 190 
corresponded to previously AD-associated genes (5,97 O.R.; Fisher-test; pval<0.05), 314 to 
PD-associated genes (3.81 O.R.; Fisher-test; pval<0.05), 142 to Multiple Sclerosis-associated 
genes (7.38 O.R.; Fisher-test; pval<0.05), and 35 to Amyotrophic lateral sclerosis-associated 
genes (28.93 O.R.; Fisher-test; pval<0.05) (supplementary table 8). A closer inspection 
revealed interesting DNA methylation profiles regarding these genes. For instance, several 
important genes associated with AD, such as Clusterin (CLU) (Harold et al., 2009) and 
microtubule-associated protein tau (MAPT)(Grundke-Iqbal et al., 1986), were hypomethylated in 
grey matter (Figure 3B). Similarly, genes associated with PD, such as Leucine-rich repeat 
kinase 2 (LRRK2)(Paisan-Ruiz et al., 2004) and PTEN Induced Putative Kinase 1 (PINK1) 
(Valente et al., 2004), were also hypomethylated in grey matter as well as Interleukin 1 
Receptor Type 1 (IL1R1) (Schrijver et al., 1999) as well as TNF receptor superfamily member 
Page 10 of 32Synapse
This article is protected by copyright. All rights reserved.
1A (TNFRSF1A) (Cereda et al., 2008), which are associated with MS and ALS respectively 
(Figure 3B).  
Discussion  
In this study, we used a novel approach to determine the specific characteristics of grey and 
white matter divisions in BA9. Acutely dissected grey and white matter from BA9 was isolated 
and its DNA extracted. WGBS and Human Infinium Human Methylation 450 BeadChip Kit 
arrays were used to determine their DNA methylation profiles and the resulting data was further 
validated by pyrosequencing.  
Despite that WGBS can provide data on CG and non-CG methylation, we decided to focus on 
CG methylation for several practical regions. First, the effect of CG methylation on gene 
regulation has largely been demonstrated (Vinson and Chatterjee, 2012). Second, CG 
methylation of neighboring CG sites is strongly correlated facilitating the application of 
smoothing algorithms that increase the power and significance of the results (Hansen et al., 
2012). Third, high-density array platforms interrogate mostly CG methylation facilitating the 
cross-validation between platforms (Sandoval et al., 2011). And finally, in contrast to the 
scattered pattern of non-CG methylation, loci of differentially CG methylation can be precisely 
determined facilitating the validation of the data using alternative techniques such as 
pyrosequencing.  
Doing so, we found an important enrichment of DMRs in functionally relevant genome regions, 
especially in enhancers, which are, in turn, strongly associated with cell-type specificity 
(Creyghton et al., 2010; Zhu et al., 2013), consistent with previous reports (Kozlenkov et al., 
2014; Sun et al., 2016). Similarly, our data show a significant negative correlation between 
promoter DNA methylation and gene expression, consistent with the idea that promoter DNA 
methylation represses RNA expression (Kelly et al., 2012). Finally, our results were also in 
agreement with the expected differences in cell type markers in grey and white matter as well 
as between grey and white matter-specific molecular pathways, supporting the biological 
significance of the observed DMRs. 
To our knowledge, our study is the first to provide a complete and detailed landscape of DNA 
methylation profiles between the anatomically distinct grey and white matter. Previous studies 
interrogating DNA methylation profiles of neuron and glial cells have used isolated NeuN-
positive cells and ChIP-on-chip assays (Iwamoto et al., 2011; Labonte et al., 2013). ChIP-on-
chip assays consist of immunoprecipitating DNA using antibodies that recognize 5mC or MBD 
proteins, a technique that is known to introduce a certain bias of sequence recognition and to be 
limited in resolution imposed by the array. Therefore, this technique can only represent a partial 
view of bona fide DNA methylation profiles. Others have used restriction enzyme-based 
methods (Kozlenkov et al., 2016; Montano et al., 2013; Sun et al., 2016) or Infinium 
HumanMethylation450 BeadChip arrays (Guintivano et al., 2013; Kozlenkov et al., 2014; 
Kozlenkov et al., 2016) that provide a broader representation of the genome but are biased to 
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CpG-rich regions. Circumventing this problem, Lister and collaborators have recently reported a  
WGBS study on isolated NeuN cells (Lister et al., 2013), which is not biased by  
immunoprecipiation and which analyzes virtually all nucleotides of the genome in a comparable  
resolution to our data. Nonetheless, all these studies are based on NeuN-stained isolation of  
cells, which does not take the spatial information or the anatomical specialization between  
different brain regions into consideration. Yet, neuron and glial cells show characteristic spatial  
expression profiles according to specific anatomical structures (Bohland et al., 2010; Ko et al.,  
2013) which are also reflected at DNA methylation profiles (Davies et al., 2012; Hernandez et  
al., 2011; Ladd-Acosta et al., 2007; Lee et al., 2011; Sanchez-Mut et al., 2013; Xin et al., 2010).   
Notwithstanding, our approach might be limited by imperfections in dissection and the impurity  
of the grey and white matter divisions and the limited number of samples analyzed.  
Furthermore, standard bisulfite conversion cannot recognize hydroxymethylation (Huang et al.,  
2010), an emerging epigenetic modification in the brain with various functions including  
cognition (Massart et al., 2014; Mellen et al., 2012), nor can we capture the highly dynamic  
nature of DNA methylation, including DNA methylation changes associated with learning and  
memory (Graff and Mansuy, 2008; Lubin et al., 2011; Miller and Sweatt, 2006; Numata et al.,  
2012).   
Interestingly, our analysis has revealed an outstanding enrichment of DMR in genes associated  
with several neurological and neurodegenerative diseases. In particular, we have observed an  
enrichment of DMRs in genes previously associated with AD, PD, HD, MS and ALS. AD- and  
PD-related genes such as CLU and MAPT, and LRRK2 and PINK1 are differentially methylated  
between grey and white matter, as well as IL1R1 and TNFRSF1A, which are associated with  
MS and ALS respectively. In line with the repressive effect of promoter DNA methylation, these  
genes tend to be hypermethylated (Figure 3B) and less expressed (Supplementary table 2) in  
white matter, where a higher proportion of glial cells are observed. In follow-up studies, it will be  
interesting to determine whether these genes are differentially methylated in brain regions  
particularly affected in neurodegenerative diseases. First attempts along this line, exemplified  
by MAPT DNA methylation, have shown a complex scenario in which the specific brain region  
DNA methylation patterns can be influenced by the genetic background and the disease status  
(Coupland et al., 2014).  
These observations indicate that genes associated with neurodegenerative diseases are  
differentially regulated between grey and white matter, which are in turn differentially affected in  
such diseases, reinforcing the necessity of considering the cellular and spatial  
compartmentalization in neurodegenerative studies. In addition, these data also suggest that  
such genes play a major role in grey matter and, by extension, in neurons, while other genes  
showing the opposite relation might need to be interpreted as glia-relevant genes. Also, since  
neurodegenerative diseases are primarily affecting particular cell types and specific brain  
regions, an alteration of the cellular ratios and spatial distribution of their specific epigenetic  
patterns are expected. As a consequence, a direct comparison between control and disease- 
Page 12 of 32Synapse
This article is protected by copyright. All rights reserved.
affected tissues should not only result in alterations underlying neurodegeneration diseases but 
also in differences between cell patterns, that can be present even in studies based on 
neuron/glia fluorescence-activated cell sorting (FACS), where a minimal contamination of cells 
cannot be completely discarded. Therefore, previous studies investigating changes in DNA 
methylation in neurodegeneration in genes showing differences between grey and white matter, 
or neuron and glial cells, ought to be carefully interpreted in light of our observations presented 
here (for a detailed revision of genes previously associated with AD see (Sanchez-Mut and 
Graff, 2015), PD see (Feng et al., 2015), MS see (Li et al., 2016), and ALS see(Paez-Colasante 
et al., 2015)). 
Taken together, the results presented here offer a complete and detailed landscape of DNA 
methylation profiles of grey and white matter in BA9 that constitutes an important resource to 
assist future studies determining cell type-specific (epigenetic) differences pertinent (or not) to 
this region of the cortex. Additionally, our data may also be relevant to unmask and better 
understand epigenetic alterations underlying neurological and neurodegenerative diseases, and 
to assist case-control studies where cell type compositions are not considered.  
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Figure 1. WGBS of Grey (G145) and White matter (W145) DMRs. (A) Circos representation of 
DMR between Grey and White matter samples. Outer circle represents average levels for all of 
DMRs in 50 Mbp-wide windows. Inner circle represents average levels for all of DMRs in 200 
Kbp-wide windows. Bars indicate the magnitude of the difference between the G145 and the 
W145 samples for each window (color scale). (B) DMR distribution among different genomic 
regions, left. DMR overlapping with different histone marks, right. Observed DMRs refers to total 
number of DMRs obtained. Expected DMRs refers to expected DMR distribution randomly 
permuting their locations among the genome. (C) DNA methylation and gene expression 
correlation. DNA promoter methylation and gene expression correlation for each of samples 
analyzed (Grey matter R =  -0.49; White matter R = -0.47; Pearson correlations, p-val <0.001).  
Figure 2. Heatmap clustering of 450K data between grey and white matter samples. CpGs 
covering WGBS DMRs were selected to cluster five grey and five white samples. Red and 
green colors indicate high and low levels of DNA methylation respectively.  
 Figure 3. DMR examples of relevant genes. (A) DMRs overlapping promoters of cell type 
markers. (B) DMRs overlapping promoters of disease-associated genes. Smoothing values for 
grey and white matter are represented by red and blue lines respectively. Dots represent single 
sequencing reads, and light red and blue areas represent the confidence interval of the data.   
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Figure 2. Heatmap clustering of 450K data between grey and white matter samples. CpGs covering WGBS 
DMRs were selected to cluster five grey and five white samples. Red and green colors indicate high and low 
levels of DNA methylation respectively.  
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Figure 3. DMR examples of relevant genes. (A) DMRs overlapping promoters of cell type markers. (B) DMRs 
overlapping promoters of disease-associated genes. Smoothing values for grey and white matter are 
represented by red and blue lines respectively. Dots represent single sequencing reads, and light red and 
blue areas represent the confidence interval of the data.  
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Table 1. Panther terms enrichments on genes differentially methylated between grey and white matter. 
Panther terms Genes Hyp* 
 Wnt signaling pathway 136 genes  4.41E-25 
 Endothelin signaling pathway 50 genes  7.42E-18 
 Angiogenesis 79 genes  8.82E-17 
 EGF receptor signaling pathway 64 genes  4.41E-16 
 PDGF signaling pathway 68 genes  1.25E-15 
 Integrin signalling pathway 78 genes  1.30E-15 
 Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway 61 genes  1.35E-15 
 Inflammation mediated by chemokine and cytokine signaling pathway 89 genes  1.82E-14 
 Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway 71 genes  4.92E-13 
 FGF signaling pathway 57 genes  6.68E-13 
 Apoptosis signaling pathway 56 genes  8.82E-13 
 Alzheimer disease-amyloid secretase pathway 41 genes  9.12E-13 
 p53 pathway 45 genes  2.19E-12 
 Muscarinic acetylcholine receptor 1 and 3 signaling pathway 36 genes  1.14E-11 
 Oxytocin receptor mediated signaling pathway 35 genes  1.59E-11 
 Ras Pathway 40 genes  3.06E-11 
 Histamine H1 receptor mediated signaling pathway 29 genes  5.28E-11 
 Thyrotropin-releasing hormone receptor signaling pathway 35 genes  5.96E-11 
 Huntington disease 58 genes  2.04E-10 
 TGF-beta signaling pathway 46 genes  4.04E-10 
 Cadherin signaling pathway 60 genes  3.01E-09 
 VEGF signaling pathway 33 genes  3.31E-09 
 Alzheimer disease-presenilin pathway 53 genes  3.57E-09 
 5HT2 type receptor mediated signaling pathway 35 genes  4.01E-09 
 Notch signaling pathway 24 genes  7.24E-09 
 GABA-B receptor II signaling 24 genes  1.61E-08 
 Metabotropic glutamate receptor group III pathway 33 genes  7.70E-08 
 Beta2 adrenergic receptor signaling pathway 25 genes  8.75E-08 
 Beta1 adrenergic receptor signaling pathway 25 genes  8.75E-08 
 Parkinson disease 40 genes  9.87E-08 
 PI3 kinase pathway 28 genes  1.37E-07 
 Muscarinic acetylcholine receptor 2 and 4 signaling pathway 29 genes  4.20E-07 
 Alpha adrenergic receptor signaling pathway 16 genes  4.94E-07 
 Metabotropic glutamate receptor group II pathway 25 genes  4.95E-07 
 B cell activation 29 genes  1.64E-06 
 Synaptic vesicle trafficking 17 genes  2.01E-06 
 Metabotropic glutamate receptor group I pathway 16 genes  2.88E-06 
 Oxidative stress response 25 genes  5.88E-06 
 Ionotropic glutamate receptor pathway 23 genes  5.90E-06 
 p53 pathway feedback loops 2 24 genes  5.96E-06 
 Histamine H2 receptor mediated signaling pathway 15 genes  8.78E-06 
 Interferon-gamma signaling pathway 17 genes  1.55E-05 
 Nicotinic acetylcholine receptor signaling pathway 36 genes  2.73E-05 
 Cytoskeletal regulation by Rho GTPase 30 genes  2.91E-05 
 Axon guidance mediated by semaphorins 13 genes  4.00E-05 
 T cell activation 32 genes  4.26E-05 
 Circadian clock system 8 genes  4.89E-05 
 Toll receptor signaling pathway 22 genes  5.00E-05 
 Hypoxia response via HIF activation 15 genes  6.28E-05 
 FAS signaling pathway 18 genes  7.98E-05 
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Using whole genome bisulfite sequencing and highthroughput arrays, the authors characterize the DNA 
methylation patterns of white and grey matter in the prefrontal cortex. Genes differentially methylated were 
found to be enriched in molecular pathways highly relevant for neuron/glia function and neurodegenerative 
diseases.  
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Using whole genome bisulfite sequencing and highthroughput arrays, the authors characterize 
the DNA methylation patterns of white and grey matter in the prefrontal cortex. Genes 
differentially methylated were found to be enriched in molecular pathways highly relevant for 
neuron/glia function and neurodegenerative diseases. 
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